Outset Medical (OM)
Provides the Tablo hemodialysis platform for hospital, clinic, and home care.
$3.13
vs last close−0.16 (−4.86%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 30 | 31 | 28 | 27 | 29 | 29 | 30 | 31 | 29 | 29 | 28 | 32 |
| Cost of revenue | 23 | 23 | 20 | 18 | 19 | 19 | 19 | 20 | 18 | 17 | 16 | 18 |
| Gross profit | 7 | 8 | 8 | 10 | 10 | 11 | 11 | 12 | 12 | 12 | 12 | 13 |
| 53 | 45 | 45 | 41 | 34 | 33 | 27 | 29 | 27 | 30 | 29 | 29 | |
| Research & development | 16 | 13 | 13 | 10 | 8 | 8 | 6 | 5 | 5 | 5 | 6 | 5 |
| 37 | 33 | 32 | 31 | 26 | 25 | 22 | 23 | 22 | 25 | 23 | 24 | |
| Selling & marketing | 25 | 22 | 21 | 18 | 15 | 15 | 14 | 14 | 14 | 13 | 13 | 12 |
| General & administrative | 12 | 10 | 11 | 13 | 10 | 9 | 8 | 9 | 8 | 12 | 10 | 11 |
| Operating income | −45 | −37 | −37 | −31 | −24 | −22 | −16 | −17 | −16 | −18 | −17 | −16 |
| −1 | −1 | −3 | −4 | −4 | −4 | −9 | −2 | −2 | −2 | −2 | −2 | |
| Interest income | 3 | 2 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 0 |
| Interest expense | 3 | 3 | 6 | 6 | 6 | 6 | 4 | 3 | 3 | 3 | 3 | 3 |
| Other non-operating income | −3 | −2 | −3 | −2 | −2 | −2 | 0 | −2 | −2 | −2 | −2 | −1 |
| Income before tax | −46 | −38 | −40 | −34 | −28 | −26 | −26 | −18 | −17 | −19 | −19 | −18 |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | −46 | −39 | −40 | −34 | −28 | −26 | −26 | −19 | −18 | −19 | −19 | −18 |
| Net income | −46 | −39 | −40 | −34 | −28 | −26 | −26 | −19 | −18 | −19 | −19 | −18 |
| EPS, basic | −$0.93 | −$0.77 | −$11.77 | −$9.96 | −$8.30 | −$7.35 | −$7.44 | −$1.04 | −$1.00 | −$1.09 | −$1.03 | −$0.97 |
| EPS, diluted | −$0.93 | −$0.77 | −$11.77 | −$9.96 | −$8.30 | −$7.35 | −$7.44 | −$1.04 | −$1.00 | −$1.09 | −$1.03 | −$0.97 |
| Weighted average shares, basic | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 18 | 18 | 18 | 18 | 19 |
| Weighted average shares, diluted | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 18 | 18 | 18 | 18 | 19 |
| EBITDA | −41 | −34 | −32 | −27 | −20 | −18 | −15 | −14 | −14 | −15 | −15 | −13 |
| Depreciation & amortization | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 0 | 1 | 1 | 1 |
| EBIT | −43 | −35 | −34 | −28 | −22 | −20 | −16 | −15 | −14 | −16 | −15 | −14 |
